1. Model‐Based Characterization of the Pharmacokinetics of Pembrolizumab: A Humanized Anti–PD‐1 Monoclonal Antibody in Advanced Solid Tumors. (14th November 2016) Authors: Ahamadi, M; Freshwater, T; Prohn, M; Li, CH; de Alwis, DP; de Greef, R; Elassaiss‐Schaap, J; Kondic, A; Stone, JA Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 1(2017) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗